¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè(AST) ½ÃÀå : Á¦Ç°º°, ¹æ¹ýº°, À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° - ¿¹Ãø(-2029³â)
Antimicrobial Susceptibility Testing Market by Product (Manual, Automated, Molecular), Method, Type, Application Global Forecasts to 2029
»óǰÄÚµå : 1587947
¸®¼­Ä¡»ç : MarketsandMarkets
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 283 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,914,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,650 £Ü 9,289,000
PDF (5-user License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,150 £Ü 11,384,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,969,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. (100% ÀÚȸ»ç´Â µ¿ÀÏ ±â¾÷À¸·Î °£Áֵ˴ϴÙ.) Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè(AST) ½ÃÀå ±Ô¸ð´Â 2024³â 44¾ï 5,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2029³â¿¡´Â 56¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 5.0%°¡ µÉ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

AST ½ÃÀåÀÇ ÁÖ¿ä ÀÌÁ¡Àº ÀûÀýÇÑ ½Äº°°ú È¿°úÀûÀÎ Ç×±ÕÁ¦ Ä¡·áÀÇ Àû½Ã ¼±ÅÃÀ» ÅëÇØ ȯÀÚ °ü¸®¸¦ °³¼±ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÏ´Ù´Â »ç½ÇÀ» Æ÷ÇÔÇÕ´Ï´Ù. Ç×±ÕÁ¦ »ç¿ëÀ» µ½´Â ¿Ã¹Ù¸¥ °¨¼ö¼º ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÔÀ¸·Î½á Ç×±ÕÁ¦ ³»¼º ¹®Á¦ Áõ°¡¿¡ ´ëÇ×ÇÏ´Â µ¥ Ãß°¡ÀûÀÎ ÀÌÁ¡ÀÌ ÀÖ½À´Ï´Ù.

Á¶»ç ¹üÀ§
Á¶»ç ´ë»ó³âµµ 2022-2029³â
±âÁسâ 2023³â
¿¹Ãø ±â°£ 2024-2029³â
°ËÅä ´ÜÀ§ ±Ý¾×(100¸¸ ´Þ·¯)
ºÎ¹®º° Á¦Ç°º°, ¹æ¹ýº°, À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°
´ë»ó Áö¿ª ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè(AST)ÀÇ ÃÖ´ë Á¡À¯À²Àº ¼Ò¸ðǰ ºÎ¹®ÀÔ´Ï´Ù. Áß¿äÇÑ Àç·á°¡ ´ë·®À¸·Î ¼Ò¸ðµÇ°í ±× ¾çÀº Áõ°¡ÀÇ ±æÀ» µû¶ó°©´Ï´Ù. À̰ÍÀº ¹èÁö, ½ÃÁ¦, Ç×»ýÁ¦ µð½ºÅ© ¹× ±âŸ Àç·á·Î ±¸¼ºµÇ¸ç AST ÀýÂ÷¿¡´Â ±âº»ÀûÀ¸·Î ÇÊ¿äÇÑ °ÍÀ¸·Î °£Áֵ˴ϴÙ. °¨¿°ÀÇ ÀÌȯÀ² Áõ°¡, Ç×»ýÁ¦ ³»¼º º´¿øÃ¼ÀÇ ÃâÇö, AST ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ¼Ò¸ðǰ ½ÃÀå Á¡À¯À²ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

µÑ°, º¸´Ù Á¤±³ÇÑ AST ±â¼úÀ» »ý»êÇÏ·Á¸é ´õ ¸¹Àº ±â¼úÀû ¼Ò¸ðǰÀÌ ÇÊ¿äÇÕ´Ï´Ù. ºÐ¸íÈ÷ ºÐÀÚ ±â¹Ý AST ¹æ¹ý¿¡´Â ƯÁ¤ ÇÙ»ê ÃßÃâ ŰƮ, PCR ½Ã¾à ¹× °ËÃâ ÇÁ·Îºê°¡ ÇÊ¿äÇÕ´Ï´Ù. Á¤È®Çϰí È¿°úÀûÀÎ AST °Ë»ç¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä´Â ¼Ò¸ðǰ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¸¦ âÃâÇÏ°í ¼Ò¸ðǰÀÌ AST ½ÃÀå ÀüüÀÇ ÇÙ½ÉÀÓÀ» ´õ¿í È®°íÈ÷ Çϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, Á¦Ç°º°, ¹æ¹ýº°, À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° µ¿Çâ ¹× ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå Áß¿ä ÀλçÀÌÆ®

Á¦5Àå ½ÃÀå °³¿ä

Á¦6Àå Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå : Á¦Ç°º°

Á¦7Àå Ç×±ÕÁ¦ °¨¼ö¼º °Ë»ç ½ÃÀå : À¯Çüº°

Á¦8Àå Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå : ¹æ¹ýº°

Á¦9Àå Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå : ¿ëµµº°

Á¦10Àå Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦11Àå Ç×±ÕÁ¦ °¨¼ö¼º °Ë»ç ½ÃÀå : Áö¿ªº°

Á¦12Àå °æÀï ±¸µµ

Á¦13Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦14Àå ºÎ·Ï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global antimicrobial susceptibility testingmarket is projected to reach USD 5.68 billion by 2029 from USD 4.45 billion in 2024, growing at a CAGR of 5.0% during the forecast period. Key advantages of the AST market include the fact that it is very crucial in improving patient care through proper identification and timely selection of effective antimicrobial therapy. AST therefore has an added advantage in combating the rise of the antimicrobial resistance problem in providing correct susceptibility profiles that assist appropriate antibiotic usage.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Million)
SegmentsBy Product, Type, Method, Application, End User and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa

"Consumables to register largest market share in 2022-2029."

The largest share in antimicrobial susceptibility testing (AST) is held by the consumables segment. A significant and ever-increasing amount of critical material is consumed. It comprises culture media, reagents, antibiotic discs, and other materials and can be considered basically necessary for AST procedures. The market share of the consumable is thus added to owing to the growing incidence of infectious diseases and the emergence of antibiotic-resistant pathogens and increasing demand for AST services.

Second, the production of more sophisticated AST technologies will need more technical consumables. Obviously, molecular-based AST methods will require specific nucleic acid extraction kits, PCR reagents, and detection probes. Persistent demand for accurate and effective AST testing creates a sustainable demand for consumables, which further solidifies them as the core of the overall AST market.

"Hospitals & diagnostic centers segment held the largest share of antimicrobial susceptibility testingmarket in 2023, by End-user."

Based on the end-user, the antimicrobial susceptibility testing market is segmented into hospitals & diagnostic laboratories, pharmaceutical and biotechnology companies, research & academic Institutes and clinical research organizations. In the year 2023, the global antimicrobial susceptibility testing market was dominated by hospitals and diagnostic centers. Growth within the number of hospitals and diagnostic centers in the AST market is also derived from increases in the timely and accurate diagnostics needs for managing infectious diseases and fighting against antimicrobial resistance.

.

"Asia Pacific to register highest growth rate in the market during the forecast period."

The Asia Pacific region, and China in particular, is witnessing a very rapid growth in the AST market due to various reasons. The increasing population in this region, allied with increasing incomes and access to better health care, has resulted in more stringent demands for diagnostics services. It is not overstressed in the sense that the ever-growing occurrence of infectious diseases and antimicrobial-resistant pathogens demands utmost importance in attaching real value to accurate AST as the primary basis for guiding proper treatment.

Advances in AST technology, particularly through the development of molecular rapid diagnostics and automated systems, is driving the market.. These speed up the process of AST, give results quicker in turn-around time, have increased efficiency with precise results, which put AST within the reach of healthcare providers. Additionally, the investments done by governments in upgrading the health care infrastructure along with such initiatives have paved a favorable path toward the growth of the market in the country, particularly in China.

A number of drivers were responsible for the upswing, including:

A breakdown of the primary participants referred to for this report is provided below:

Prominent players in this market are BioMerieux (France), Becton, Dickinson and company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Bio-Rad laboratories (US), Bruker (US), Roche diagnostics (Switzerland, Accelerate diagnostics (US), Himedia laboratories (India), Liofilchem s.r.l.(Italy), Alifax s.r.l.(Italy), Creative Diagnostics (US), among others.

Research Coverage

The market is segmented into product, type, method, application, end user, and region. In the report, factors affecting the antimicrobial susceptibility testing market- drivers, restraints, opportunities, and challenges-are described. Opportunities and challenges for stakeholders and the details of leading players' competitive landscape are also highlighted. The report further segments the micro-markets into growth trends, prospects, and contribution to the antimicrobial susceptibility testing market. It forecasts revenue growth from different market segments, focusing on five major geographical regions.

Key Benefits of Buying the Report:

The report is designed to aid new entrants by providing them with detailed data on the antimicrobial susceptibility testing market, thereby allowing them to understand investment opportunities. It provides comprehensive insight into key players as well as smaller ones, thus favoring strong risk assessment and informed investment decisions. Due to precise segmentation-such as by end-users and regions-the report offers focused insights in specific segments of the market. It further outlines the critical trends, challenges, growth drivers, and opportunities that complete the strategic decision-making process with well-rounded analysis.

The report provides the insights on the following pointers:

Analysis of the key drivers, restraints, opportunities, and challenges influencing the rise of the antimicrobial susceptibility testing market. The key drivers of antimicrobial susceptibility testing are an upsurge in infectious diseases and, correspondingly, higher numbers of antibiotic resistance around the world. Growing demand for timely and accurate diagnostic tools that guide effective treatment strategies fuels demand for AST. Technologically, the development of rapid and automated testing systems supports market growth by increasing efficiency and accuracy in tests.

Product Development/Innovation: Insights into emerging technologies, current R&D activities, and recent launches of products and services in the antimicrobial susceptibility testing market.

Market Development: The report further provides in detail the profitable markets by segmenting the antimicrobial susceptibility testing market into various regions

Market Diversification: Detailed insight into new product launches, unexplored markets, recent developments, and investments made in the antimicrobial susceptibility testing market.

Competitive Assessment: Detailed assessment of market share, service offerings leading strategies of key players such as BioMerieux (France), Becton, Dickinson and company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Bio-Rad laboratories (US), among others.

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT

7 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE

8 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD

9 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION

10 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER

11 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION

12 COMPETITIVE LANDSCAPE

13 COMPANY PROFILES

14 APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â